SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Nexia Biotechnologies Inc. Completes Sale Of Protexia Operations, Assets To PharmAthene, Inc.; PharmAthene Closes $11.2 Series C
Your Message